With a 25% annual mortality of aortic stenosis patients, you want to perform the procedure as soon as possible after enrolling each patient.
A 2020 study done in Canada showed a median wait time for TAVR patients of 84 days and mortality during the wait was pretty high at 5.7%. There was also a probability of heart failure hospitalization of 7.7% during the wait so doing the procedure ASAP saves lives. I'm pretty sure that our pivotal trial will have a rolling enrollment/implantation.
https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.120.009297
$66.32 price target - Evolution Capital initiation of coverage, page-8
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.49 |
Change
0.490(4.08%) |
Mkt cap ! $264.0M | |||
| Open | High | Low | Value | Volume |
| $12.11 | $12.49 | $11.50 | $155.8K | 13.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 175 | $11.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.49 | 77 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |